President Donald Trump’s pick to lead the US Food and Drug Administration told senators in a tense confirmation hearing ...
Marty Makary wouldn't commit to maintaining current access to mifepristone during his Senate confirmation hearing on Thursday ...
WASHINGTON — President Donald Trump’s nominee to lead the Food and Drug Administration refused to commit to keeping access to ...
FDA approval, and medication availability; and not necessarily guided by evidence-based practice. For example, some obstetric providers choose to use misoprostol off-label because it is stable at ...
The U.S. Food and Drug Administration’s (FDA’s) reckless removal of safety protocols from the “mifepristone + misoprostol” abortion drug regimen is the latest move in a long line of ...
Missouri’s Attorney General announced he was going to file a cease and desist against Planned Parenthood facilities in the ...
If confirmed as FDA commissioner, Makary will report to ... in which someone ends their pregnancy by taking two pills – mifepristone and misoprostol – rather than having a surgical procedure.